MYCN and medulloblastoma: In MYCN-driven neuroblastoma and medulloblastoma mouse models, the PI3K inhibitors PIK-75 and PW-12 have been shown to induce tumor apoptosis by disrupting N-Myc stability (Cage et al., 2015).